One of three protected witnesses in a controversial – an ultimately futile – investigation into allegations of kickbacks and bribes by Novartis’ subsidiary in Greece was reportedly arrested on charges of defrauding unsuspecting businesspeople.
Greek Police (EL.AS) announced the arrests of three suspects on Tuesday, as part of a probe into allegations of fraud.
One of the suspects, according to initial reports is «Maximos Sarafis», the alias used by one of the three protected witnesses. Authorities said the suspects presented themselves as executives of a foreign credit institution, promising fast-track loans in return for «filing fees» and «commissions» that required upfront payment. No loans were ever forthcoming.
Police said at least 10 business people were duped, with nearly a half million euros collected by the alleged perpetrators.
The explosive Novartis judicial probe in Greece, led by the former head of the anti-corruption prosecutor’s office, Eleni Touloupaki, ended in a fiasco after years of investigation, mostly over a period coinciding with a leftist SYRIZA government in office (2015-19).
Claims by the trio of protected witnesses involved hefty bribes and kickbacks funneled by Novartis Greece to 10 top office-holders in the country, including former prime ministers, health ministers and others, all rivals of then ruling SYRIZA.
A Parliament majority at one point authorized the continued investigation of the 10 politicians, lifting their immunity, as most were members of Parliament.
However, Touloupaki and her associate prosecutors failed to file even one indictment, a development that would have required corroborating evidence be presented. All 10 cases were eventually shelved.
Conversely, a US Justice Department settlement with Novartis in June 2020 resulted in a fine against the Swiss multinational of 345 million USD to resolve a “Foreign Corrupt Practices Act” case, as the US federal law is called.
In a statement issued at the time, the US Attorney’s office in New Jersey noted, among others, that “…The resolutions arise out of a Novartis Greece scheme to bribe employees of state-owned and state-controlled hospitals and clinics in Greece and to falsely record improper payments relating to the corrupt scheme and similar conduct…”
However, although the high-profile focus of the judicial investigation in Greece almost exclusively revolved around the claims against the 10 politicians, no evidence was ever gathered against such officials at state-owned and controlled hospitals and clinics.
The “Novartis scandal”, according to the then SYRIZA government, or “Novartis conspiracy”, according to the opposition, sparked an intense political firestorm in the country before the July 2019 general election.
One of the results of the subsequent fallout is that the former head of the anti-corruption office now finds herself as the defendant, on misdemeanor charges, in trial related to the botched Novartis probe.
Latest News
Intrum’s 2024 Report Unveils Greek Businesses Embrace Digitalization for Growth
Looking ahead, over 40% of businesses prioritize development for 2024, with 65% recognizing the potential of digital business models as sustainable investments
IOBE: Mild Drop in April Business Confidence Index (BCI) in Greece
The positive balance of expectations for employment witnessed a marginal decline, while the index for production forecasts also recorded a mild drop
Greek PM Mitsotakis Calls on EU to Intervene Over Multinationals’ Pricing Policy
Speaking about price fairness, the Prime Minister emphasized, "Europe should also mean similar or uniform prices for the products sold by our multinational corporations.
Greenhouse Gas Emissions: 4% Decrease in EU, 0.3% Rise in Greece in Q4 2023
The EU's GDP remained stable with a marginal 0.2% increase in fourth quarter of 2023
HEREMA CEO: High Expectations from Natgas Exploration Off Crete
3D seismic surveys were conducted in the two offshore blocks west and southwest of Crete by a consortium comprised of ExxonMobil and HelleniQ Energy
EC Spring Forecast: Greek GDP at 2.2 in 2024, 2.3% in 2025
Besides Greek GDP inflation is expected to drop by a substantial 2.4% in 2024, settling at 2.8% from 4.2% in 2023 with 2025 recording a further decline to 2.1%
EBRD Raises Outlook for Greek GDP to 2.3% in 2024, 2.6% in 2025
Key downside risks remain, associated with possible delays in deploying Recovery and Resilience Facility (RRF) funds and weaknesses in key export markets and tourism source countries
Real Estate Insights: Athens’ Top Areas with the Highest Yields
In the first quarter of 2024, Korydallos in the Piraeus region and the burgeoning Attiki Square retain their top spots with impressive yields of 6.3%
ELSTAT: Inflation at 3.1% in April
Olive oil (63.7%), fruit (11.6%), fish (10.6%), and mineral water (12.5%) registered the highest increases annually
Greek Sunlight CEO Joins Industry Titans at Choose France Summit
At the heart of the "Choose France Summit" was the discussion surrounding the production of lead-acid and lithium-ion batteries, crucial for the green transition and storage of renewable energy.